Showing 1 - 9 results of 9 for search 'Matteo Morotti', query time: 0.03s Refine Results
  1. 1
    Transdiaphragmatic resection of enlarged cardiophrenic lymph node during interval debulking surgery for advanced ovarian cancer

    Transdiaphragmatic resection of enlarged cardiophrenic lymph node during interval debulking surgery for advanced ovarian cancer by Susan Addley, Matteo Morotti, Ciro Pinelli, Hooman Soleymani majd

    Published 2021-08-01
    Get full text
    Article
  2. 2
    The Feasibility of Cardiophrenic Lymphnode Assessment and Removal in Patients Requiring Diaphragmatic Resection During Interval Debulking Surgery for Ovarian Cancer

    The Feasibility of Cardiophrenic Lymphnode Assessment and Removal in Patients Requiring Diaphragmatic Resection During Interval Debulking Surgery for Ovarian Cancer by Ciro Pinelli, Matteo Morotti, Jvan Casarin, Roberto Tozzi, Moiad Alazzam, Vasileios K. Mavroeidis, Hooman Soleymani majd

    Published 2021-08-01
    Get full text
    Article
  3. 3
    Patient-reported outcomes in adoptive cell-therapy trials: mind the gap

    Patient-reported outcomes in adoptive cell-therapy trials: mind the gap by Manuela Eicher, Massimo Di Maio, George Coukos, Lionel Trueb, Matteo Morotti, Eleonora Ghisoni, Sara Colomer-Lahiguera

    Published 2022-12-01
    Get full text
    Article
  4. 4
    Unexpectedly High Levels of Inverted Re-Insertions Using Paired sgRNAs for Genomic Deletions

    Unexpectedly High Levels of Inverted Re-Insertions Using Paired sgRNAs for Genomic Deletions by Joseph Blayney, Evangeline M. Foster, Marta Jagielowicz, Mira Kreuzer, Matteo Morotti, Katharina Reglinski, Julie Huiyuan Xiao, Philip Hublitz

    Published 2020-07-01
    Get full text
    Article
  5. 5
    Interval Debulking Surgery for Advanced Ovarian Cancer in Elderly Patients (≥70 y): Does the Age Matter?

    Interval Debulking Surgery for Advanced Ovarian Cancer in Elderly Patients (≥70 y): Does the Age Matter? by Ciro Pinelli, Matteo Morotti, Jvan Casarin, Roberto Tozzi, Fabio Ghezzi, Vasileios K. Mavroeidis, Moiad Alazzam, Hooman Soleymani majd

    Published 2021-08-01
    Get full text
    Article
  6. 6
    Mechanistic Drivers of Müllerian Duct Development and Differentiation Into the Oviduct

    Mechanistic Drivers of Müllerian Duct Development and Differentiation Into the Oviduct by Laura Santana Gonzalez, Laura Santana Gonzalez, Ioanna A. Rota, Ioanna A. Rota, Mara Artibani, Mara Artibani, Mara Artibani, Matteo Morotti, Matteo Morotti, Zhiyuan Hu, Zhiyuan Hu, Nina Wietek, Nina Wietek, Abdulkhaliq Alsaadi, Abdulkhaliq Alsaadi, Ashwag Albukhari, Tatjana Sauka-Spengler, Tatjana Sauka-Spengler, Ahmed A. Ahmed, Ahmed A. Ahmed

    Published 2021-03-01
    Get full text
    Article
  7. 7
    Lymph Node Involvement in Early-Stage Cervical Cancer: Is Lymphangiogenesis a Risk Factor? Results from the MICROCOL Study

    Lymph Node Involvement in Early-Stage Cervical Cancer: Is Lymphangiogenesis a Risk Factor? Results from the MICROCOL Study by Matteo Tantari, Stefano Bogliolo, Matteo Morotti, Vincent Balaya, Florent Bouttitie, Annie Buenerd, Laurent Magaud, Fabrice Lecuru, Benedetta Guani, Patrice Mathevet, on behalf of the SENTICOL Group

    Published 2022-01-01
    Get full text
    Article
  8. 8
    Single-cell transcriptomics identifies a WNT7A-FZD5 signaling axis that maintains fallopian tube stem cells in patient-derived organoids

    Single-cell transcriptomics identifies a WNT7A-FZD5 signaling axis that maintains fallopian tube stem cells in patient-derived organoids by Abdulkhaliq Alsaadi, Mara Artibani, Zhiyuan Hu, Nina Wietek, Matteo Morotti, Laura Santana Gonzalez, Moiad Alazzam, Jason Jiang, Beena Abdul, Hooman Soleymani majd, Levi L. Blazer, Jarret Adams, Francesca Silvestri, Sachdev S. Sidhu, Joan S. Brugge, Ahmed Ashour Ahmed

    Published 2023-11-01
    Get full text
    Article
  9. 9
    Adipocyte-like signature in ovarian cancer minimal residual disease identifies metabolic vulnerabilities of tumor-initiating cells

    Adipocyte-like signature in ovarian cancer minimal residual disease identifies metabolic vulnerabilities of tumor-initiating cells by Mara Artibani, Kenta Masuda, Zhiyuan Hu, Pascal C. Rauher, Garry Mallett, Nina Wietek, Matteo Morotti, Kay Chong, Mohammad KaramiNejadRanjbar, Christos E. Zois, Sunanda Dhar, Salma El-Sahhar, Leticia Campo, Sarah P. Blagden, Stephen Damato, Pubudu N. Pathiraja, Shibani Nicum, Fergus Gleeson, Alexandros Laios, Abdulkhaliq Alsaadi, Laura Santana Gonzalez, Takeshi Motohara, Ashwag Albukhari, Zhen Lu, Robert C. Bast Jr., Adrian L. Harris, Christer S. Ejsing, Robin W. Klemm, Christopher Yau, Tatjana Sauka-Spengler, Ahmed Ashour Ahmed

    Published 2021-06-01
    Get full text
    Article

Search Tools: